Alogliptin Benzoate

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

38 API Suppliers, 13 USDMF, 1 JDMF, 9 EU WC, 12 KDMF, 6 NDC API, 28 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

3 Drugs in Development

3 Drugs in Development

INTERMEDIATES

29 API Suppliers

29 API Suppliers

FINISHED DOSAGE FORMULATIONS

66 FDF Dossiers, 19 FDA Orange Book, 22 Europe, 6 Canada, 6 Australia, 13 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 12.5MG BASE;1GM, TABLET;ORAL - EQ 12.5MG BASE;500MG, TABLET;ORAL - EQ 12.5MG BASE, TABLET;ORAL - EQ 25MG BASE, TABLET;ORAL - EQ 6.25MG BASE

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 13 SPI Pharma, 3 DKSH, 1 Jai Radhe Sales, 1 Boai NKY Pharmaceuticals Ltd, 10 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 1 Aeon Procare, 5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 10 BASF, 5 DFE Pharma, 6 Gangwal Chemicals, 1 Ideal Cures Pvt Ltd, 2 Ingredion Pharma Solutions, 19 Kerry, 12 Microlex e.U, 1 Novo Excipients, 2 Pharmatrans-Sanaq, 5 Pluviaendo, 3 Prachin Chemical, 13 Roquette, 1 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 1 Ulanqab Kema New Material, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

65 Fillers, Diluents & Binders, 32 Direct Compression, 18 Granulation, 16 Disintegrants & Superdisintegrants, 15 Co-Processed Excipients, 12 Lubricants & Glidants, 12 Thickeners and Stabilizers, 11 Taste Masking, 11 Chewable & Orodispersible Aids, 10 Coating Systems & Additives, 8 Controlled & Modified Release, 7 Parenteral, 7 Solubilizers, 5 Film Formers & Plasticizers, 3 Coloring Agents, 2 Rheology Modifiers, 1 API Stability Enhancers, 1 Emulsifying Agents

DIGITAL CONTENT

3 DATA COMPILATION #PharmaFlow, 19 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

4 US Medicaid Prescriptions, 19 Finished Drug Prices, 6 Annual Reports

MARKET PLACE

6 APIs

6 APIs

PATENTS & EXCLUSIVITIES

44 US Patents, 5 US Exclusivities, 9 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 Others

2 Others

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 22271 / DOSAGE - TABLET;ORAL - EQ 12.5MG BASE

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
Alogliptin Benzoate(UNII: EEN99869SC) (Alogliptin - UNII:JHC049LO86)	Alogliptin	25mg \| 12.5mg \| 6.25mg

Inactive Ingredients

Ingredient Name	Padagis Israel Pharmaceuticals Ltd
Alcohol(3K9958V90M)
Butyl Alcohol(8PJ61P6TS3)
Croscarmellose sodium(M28OL1HH48)
Ferric oxide Red(1K09F3G675)
Ferric oxide Yellow(EX438O2MRT)
Ferrosoferric oxide(XM0M87F357)
HYDROXYPROPYL CELLULOSE (90000 WAMW)(UKE75GEA7F)
Hypromellose 2910 (6 MPA.S)(0WZ8WG20P6)
Magnesium stearate(70097M6I30)
Mannitol(3OWL53L36A)
Microcrystalline Cellulose(OP1R32D61U)
Polyethylene Glycol 8000(Q662QK8M3B)
Shellac(46N107B71O)
Titanium dioxide(15FIX9V2JP)

Drug Product Composition: Alogliptin Benzoate